跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Myozyme - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Myozyme
Approved
STANDARD
Myozyme
Genzyme Ireland Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
7f0872cc9904ff5e
Company
Genzyme Ireland Limited
Type
Standard
Approval Details
Approval Id
7f0872cc9904ff5e
Drug Approval Philippines Name
Myozyme
Product Name
Myozyme
Registration Number
BR-893
Brand Name
Myozyme
Generic Name
Alglucosidase alfa
Dosage Form
Powder For Concentrate For Solutions For Infusion (IV)
Dosage Strength
50 mg
Manufacturer
Genzyme Ireland Limited
Importer
Sanofi-Aventis Philippines, Inc.
Distributor
Sanofi-Aventis Philippines, Inc.
Company Detail Path
/organization/genzyme-ireland-limited
Issuance Date
26 April 2023
Expiry Date
31 January 2028
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
7f0872cc9904ff5e
Type
Standard
Back to Philippines FDA Approvals